Pegylated interferon alpha 2a is an effective and well‐tolerated treatment option for lymphocyte‐variant hypereosinophilic syndrome. (13th November 2019) - Choi, Charles; Moller, Daniel; Tan, Julia; Dou, Carol; Peterson, Erica A.; Medvedev, Nadia; Dutz, Jan P; Carruthers, Mollie N.; Chen, Luke Y. C.